News

The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear ...
The active ingredient in Tryptyr is acoltremon, an agonist of transient receptor potential melastatin 8 thermoreceptors.
Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S.
The FDA approved Tryptyr to treat the signs and symptoms of dry eye disease, according to a press release from Alcon. Tryptyr ...
Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first ...
Eye-care drugmaker Alcon said on Wednesday that the U.S. Food and Drug Administration has approved its treatment for dry eye disease (DED).
Alcon Inc. (NYSE:ALC) has announced that the U.S. Food and Drug Administration (FDA) has approved TRYPTYR (acoltremon ...
All eye drop users should check out the FDA's list of 26 different eye drops that could cause infection or even blindness. The FDA has reported that Velocity Pharma manufactured its eye drops under ...
The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...
Depending on the weather, the water supply could rise as high as 65% of normal, but could drop to as low as 31% of normal, the bureau predicts. Central Washington will be warmer and drier in June ...
You can then fax this to 931-292-6229 or email [email protected]. Eye drops are used to treat many conditions, from minor irritants to chronic vision problems. Optometrists and ...
Read full article: ‘Freedom certainly is not free’: Hundreds of American flags line Jacksonville’s Memorial Park to honor community heroes Read full article: Jacksonville family asks for ...